NCT03835104

Brief Summary

This study aims to assess the accuracy of a novel urine test for diagnosing urinary tract infections in acutely ill children presenting to ambulatory care. The accuracy of this novel test will be compared to the accuracy of conventional dipstick testing. In addition, the evidence on urine tests will be added to the existing algorithm for diagnosing serious infections in children. Finally, the study aims to describe the relation between the CRP level at study entry and the duration of symptoms and final diagnosis over the following 30 days.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
868

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 8, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

February 12, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2020

Completed
Last Updated

June 3, 2021

Status Verified

May 1, 2021

Enrollment Period

1.3 years

First QC Date

January 29, 2019

Last Update Submit

May 31, 2021

Conditions

Keywords

diagnosissensitivity and specificityserious infections

Outcome Measures

Primary Outcomes (1)

  • Urinary tract infection

    The number of children with a urinary tract infection based on urine culture

    3 days

Secondary Outcomes (1)

  • Serious infections

    30 days

Other Outcomes (5)

  • Final diagnosis

    30 days

  • Duration of symptoms

    30 days

  • Healthcare resource use

    30 days

  • +2 more other outcomes

Study Arms (2)

CRP in all

ACTIVE COMPARATOR

All children will undergo a CRP point-of-care test using a fingerprick of blood and producing a result within 4 minutes using the Afinion 2 (Abbott). There will be only 1 test at study entry

Device: CRP point-of-care testing

CRP in high risk children only

EXPERIMENTAL

Children who are positive on a clinical prediction rule for serious infections in children will undergo CRP point-of-care test using a fingerprick of blood and producing a result within 4 minutes using the Afinion 2 (Abbott). There will be only 1 test at study entry

Device: CRP point-of-care testing

Interventions

CRP point-of-care test using a fingerprick of blood and producing a result within 4 minutes, using the Afinion 2 (Abbott)

CRP in allCRP in high risk children only

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 3 months to 18 years
  • Presenting to a general practice or community paediatrics
  • Acute illness of a maximum of 10 days
  • Parent or guardian is willing and able to give informed consent for participation

You may not qualify if:

  • Clinically unstable warranting immediate care
  • Urinary catheter in situ
  • Immunosuppressant medication taken in the previous 30 days
  • Trauma is the main presenting problem
  • Antibiotics taken in the previous 7 days
  • Children who present to community paediatrics as a result of direct GP referral

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, 3000, Belgium

Location

Related Publications (1)

  • Boon HA, De Burghgraeve T, Verbakel JY, Van den Bruel A. Point-of-care tests for pediatric urinary tract infections in general practice: a diagnostic accuracy study. Fam Pract. 2022 Jul 19;39(4):616-622. doi: 10.1093/fampra/cmab118.

MeSH Terms

Conditions

InfectionsDiseaseHypersensitivity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsImmune System Diseases

Study Officials

  • Ann Van den Bruel, MD PhD

    ACHG, KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: The study is a cluster randomized controlled trial. The general practice is the unit of cluster.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 29, 2019

First Posted

February 8, 2019

Study Start

February 12, 2019

Primary Completion

May 22, 2020

Study Completion

May 22, 2020

Last Updated

June 3, 2021

Record last verified: 2021-05

Locations